Punch & Associates Investment Man has recently announced that it has increased stake in Charles & Colvard Ltd. (NASDAQ:CTHR) by 0.09%. After grabbing 1.92 million shares, the institutional investor is now in possession of 1675.0 shares of the Consumer Cyclical Company. The new investment brought the stake of investor firm to 6.33% having worth around $1.58 million. Moreover, Meros Investment Management L.P. increased its share by 12411.0 to have a control over 0.65 million shares. And Victory Capital Management, Inc. raised its holdings to 7770.0 shares by acquiring 0.31 million shares or 1.01% of the stake.
Charles & Colvard Ltd. (CTHR) concluded trading on 01/18/23 at a closing price of $0.92, with 0.2 million shares of worth about $0.18 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -29.47% during that period and on Wednesday the price saw a loss of about -4.43%. Currently the company’s common shares owned by public are about 30.43M shares, out of which, 25.04M shares are available for trading.
A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 1 analysts are covering the CTHR stock and their offered price forecasts bring an average price target of $1.10. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $1.10 and could fall to a lowest price of $1.10. The stock’s current price level is 16.36% above of average price target set by the analysts, while a rise to estimated low would result in gain of 16.36% for the stock. However, touching the estimated high of $1.10 would mean a gain of 16.36% for the stock.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 25 times over the past 12 months. They bought 423,517 shares in 21 of the transactions. In 4 selling transactions, insiders dumped 95,626 shares.
Vanguard Total Stock Market Index, Vanguard Extended Market Index Fu, and London Life Growth Equity Fund are the top 3 mutual funds which are holding stakes in Charles & Colvard Ltd. Vanguard Total Stock Market Index is currently holding 0.61 million shares of worth totaling $0.5 million. The company recently came buying 0.0 shares which brought its stake up to 2.01% of the company’s outstanding shares. London Life Growth Equity Fund, after buying 0.26 million shares, have now control over 0.86% of the stake in the company. It holds 0.26 million shares of worth $0.22 million.
Charles & Colvard Ltd. (NASDAQ: CTHR) started trading at $0.9763, above $0.01 from concluding price of the previous day. However, the stock later moved at a day high price of 0.9763, or with a loss of -4.43%. Stock saw a price change of -6.70% in past 5 days and over the past one month there was a price change of 10.75%. Year-to-date (YTD), CTHR shares are showing a performance of 12.34% which decreased to -63.76% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.80 but also hit the highest price of $2.58 during that period. The average intraday trading volume for Charles & Colvard Ltd. shares is 69.45K. The stock is currently trading 4.51% above its 20-day simple moving average (SMA20), while that difference is up 2.49% for SMA50 and it goes to -21.72% lower than SMA200.
Punch & Associates Investment Man acquired 1.92 million shares of Charles & Colvard Ltd. having value of about $1.58 million. Data submitted at the U.S SEC by Punch & Associates Investment Man revealed that the firm now holds 1675.0 shares in the company valued at close to $1541.0, or have control over 0.09% stake in the company. Charles & Colvard Ltd. (NASDAQ: CTHR) currently have 30.43M outstanding shares and institutions hold larger chunk of about 25.30% of that. Holding of mutual funds in the company is about 39.87% while other institutional holders and individual stake holders have control over 6.83% and 18.28% of the stake respectively.
The stock has a current market capitalization of $28.29M and its 3Y-monthly beta is at 0.58. PE ratio of stock for trailing 12 months is 46.20, while it has posted earnings per share of $0.02 in the same period. Its PEG reads 1.54 and has Quick Ratio of 2.90 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CTHR, volatility over the week remained 6.21% while standing at 6.11% over the month.
Analysts are in expectations that Charles & Colvard Ltd. (CTHR) stock would likely to be making an EPS of -$0.02 in the current quarter, while forecast for next quarter EPS is $0 and it is $0 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.02 which is -$0.02 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.03 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -82.10% while it is estimated to increase by 33.30% in next year. EPS is likely to shrink at an annualized rate of 30.00% for next 5-years, compared to annual growth of 40.80% made by the stock over the past 5-years.
Analysts at 1 brokerage firms have issued recommendations for the Charles & Colvard Ltd. (CTHR)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 1 Wall Street analysts, 1 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Coverage by Northland Securities stated Charles & Colvard Ltd. (CTHR) stock as a Market perform in their note to investors on February 22, 2008, suggesting a price target of $2 for the stock. On October 24, 2007, Northland Securities Downgrade their recommendations, while on August 06, 2007, B. Riley & Co Initiated their ratings for the stock with a price target of $8. Stock get an Outperform rating from Northland Securities on July 24, 2007.